![](/img/cover-not-exists.png)
P255âSecukinumab provides sustained improvement in nail psoriasis and inhibition of radiographic progression in PsA patients with nail phenotype: 52-week results from a Phase 3 study
Kirkham, Bruce, Nash, Peter, Mease, Philip J, Balsa, Alejandro C, Singhal, Atul, Quebe-Fehling, Erhard, Pricop, Luminita, Gaillez, CorineVolume:
59
Journal:
Rheumatology
DOI:
10.1093/rheumatology/keaa111.248
Date:
April, 2020
File:
PDF, 68 KB
2020